so.cardoso
TL2 · Chennai
Contributes reviews on supplier material. Based in Chennai.
Joined 11 September 2024 · last posted 2d
80Posts here
0Topics
2Solutions
390Likes received
270Likes given
20Badges
132Days visited
1.3kPosts read
Recent activity
Full stream-
Journal club: what we got wrong in an earlier session Replied, post #123 · Evidence › Journal club · 26 Jul 2026 · 0 likes I read post #121 twice before replying, because I had assumed the opposite. The baseline characteristics table is the single most useful page for the questions that get…
-
What is genuinely unknown about long-term amylin agonism Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2026 · 14 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Reading a home test result without over-claiming Replied, post #126 · Analytics › Home & field testing · 19 Jul 2026 · 4 likes Post #122 put the caveat in the right place and I want to underline it. Nothing available at home distinguishes a correct sequence from a closely related incorrect one.…
-
Revisiting: The best-written scientific paper you have read Replied, post #95 · Lounge › Off topic · 16 Jul 2026 · 14 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #52 · Practice › Side effects · 15 Jul 2026 · 8 likes What I would want before treating Muscle cramps as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #26 · Compounds › Repair & healing peptides · 12 Jul 2026 · 25 likes Where the absence of controlled human data discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are…
-
A structured critique template this community uses — a second dataset Replied, post #33 · Evidence › Study critique · 9 Jul 2026 · 24 likes Post #29 put the caveat in the right place and I want to underline it. A note on how structured critique template gets discussed rather than on structured critique…
-
Second pass at: Reading a trial's population section before its results Replied, post #3 · marked as the solution · Evidence › Trials · 9 Jul 2026 · 12 likes I read the opening post twice before replying, because I had assumed the opposite. A trial that answers a slightly different question from the one you have is the…
-
Pooling trials with different estimands Replied, post #81 · Evidence › Meta-analyses · 8 Jul 2026 · 3 likes Narrowing post #78, because the general version has more than one answer. Study quality and weighting: some meta-analyses weight all studies equally; others weight by…
-
Insurance and replacement policies, compared Replied, post #58 · Sourcing › Logistics · 2 Jul 2026 · 0 likes A request rather than an answer: could whoever has the primary source for insurance and replacement policies post it? I have seen the claim three times this month and…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #40 · Compounds › Tirzepatide · 16 Jun 2026 · 0 likes Where I part company with post #38, and it is a narrow parting. The published pharmacokinetics show dose proportionality across the studied range, which means dose…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #87 · Evidence › Journal club · 15 Jun 2026 · 11 likes What I can speak to on indirect comparison is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.